pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-921 |
Genomic Coordinates | chr1: 166154743 - 166154798 |
Synonyms | MIRN921, hsa-mir-921, MIR921 |
Description | Homo sapiens miR-921 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-921 | ||||||||||||
Sequence | 2| CUAGUGAGGGACAGAACCAGGAUUC |26 | ||||||||||||
Evidence | Experimental | ||||||||||||
Experiments | Cloned | DRVs in miRNA |
|
||||||||||
SNPs in miRNA |
|
||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | SFXN4 | ||||||||||||||||||||
Synonyms | BCRM1, COXPD18 | ||||||||||||||||||||
Description | sideroflexin 4 | ||||||||||||||||||||
Transcript | NM_213649 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on SFXN4 | |||||||||||||||||||||
3'UTR of SFXN4 (miRNA target sites are highlighted) |
>SFXN4|NM_213649|3'UTR 1 GCGTGAGTTTTAGGTGAATTTATGTGGTTCCTGCTTGAAAACCTTCCCCTCTCCAGGTTCGGTTTAGAGAACTTTGCCAC 81 AGGTCTTCTGGGGACCCCAGAGGTGTCTGTGCTGACAAGGCGACTTCAGATTCCATACTGAGATCGTTCCCAGGCTGGCG 161 TCTCTGGGGTTTTTAAGGCTGGCTGGAGAAGACAGTGGGAGGGTGCCCCGTCTGACACCCCTGGGGTTGCTGAGGGAACG 241 GTTGGAGTGGGGATCGGCCTGCGAAAGGATACTGTGAAATCACTAATTAACTAATAAACCTGTCTCAAGTTGAGGATTTG 321 AAGAAAGAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_213649 | 3UTR | UGGAGUGGGGAUCGGCCUGCGAAAGGAUACUGUGAAAUCACUAAUUAACUAAUAAACCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_213649 | 3UTR | AGUGGGGAUCGGCCUGCGAAAGGAUACUGUGAAAUCACUAAUUAACUAAUAAACCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903837 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_b |
Location of target site | NM_213649 | 3UTR | AACGGUUGGAGUGGGGAUCGGCCUGCGAAAGGAUACUGUGAAAUCACUAAUUAACUAAUAAACCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_213649 | 3UTR | AGUGGGAGGGUGCCCCGUCUGACACCCCUGGGGUUGCUGAGGGAACGGUUGGAGUGGGGAUCGGCCUGCGAAAGGAUACUGUGAAAUCACUAAUUAACUAAUAAACCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000355697.2 | 3UTR | CCUGCGAAAGGAUACUGUGAAAUCACUAAUUAACUAAUAAACCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
63 hsa-miR-921 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT054764 | ANGPTL1 | angiopoietin like 1 | 3 | 1 | ||||||||
MIRT066171 | PIP4K2C | phosphatidylinositol-5-phosphate 4-kinase type 2 gamma | 2 | 2 | ||||||||
MIRT069409 | ZFYVE21 | zinc finger FYVE-type containing 21 | 2 | 8 | ||||||||
MIRT102284 | DNAJB9 | DnaJ heat shock protein family (Hsp40) member B9 | 2 | 4 | ||||||||
MIRT107595 | DNAJA1 | DnaJ heat shock protein family (Hsp40) member A1 | 2 | 6 | ||||||||
MIRT178618 | HIAT1 | major facilitator superfamily domain containing 14A | 2 | 2 | ||||||||
MIRT182407 | TIPRL | TOR signaling pathway regulator | 2 | 4 | ||||||||
MIRT186552 | ZBTB18 | zinc finger and BTB domain containing 18 | 2 | 2 | ||||||||
MIRT273662 | HOXC8 | homeobox C8 | 2 | 2 | ||||||||
MIRT283191 | C16ORF52 | chromosome 16 open reading frame 52 | 2 | 2 | ||||||||
MIRT284890 | NFAT5 | nuclear factor of activated T-cells 5 | 2 | 2 | ||||||||
MIRT347670 | LSM14A | LSM14A, mRNA processing body assembly factor | 2 | 2 | ||||||||
MIRT400222 | SLC35F6 | solute carrier family 35 member F6 | 2 | 2 | ||||||||
MIRT403517 | ASPH | aspartate beta-hydroxylase | 2 | 2 | ||||||||
MIRT442251 | DCTN5 | dynactin subunit 5 | 2 | 2 | ||||||||
MIRT443023 | SDR39U1 | short chain dehydrogenase/reductase family 39U member 1 | 2 | 2 | ||||||||
MIRT443097 | RNF20 | ring finger protein 20 | 2 | 2 | ||||||||
MIRT444560 | TRA2B | transformer 2 beta homolog | 2 | 2 | ||||||||
MIRT445696 | PRKG1 | protein kinase, cGMP-dependent, type I | 2 | 2 | ||||||||
MIRT454084 | TMEM209 | transmembrane protein 209 | 2 | 2 | ||||||||
MIRT455463 | LYPLA2 | lysophospholipase II | 2 | 2 | ||||||||
MIRT456653 | TIFA | TRAF interacting protein with forkhead associated domain | 2 | 2 | ||||||||
MIRT458147 | LYRM4 | LYR motif containing 4 | 2 | 6 | ||||||||
MIRT467073 | SRRD | SRR1 domain containing | 2 | 4 | ||||||||
MIRT467245 | SPPL2A | signal peptide peptidase like 2A | 2 | 2 | ||||||||
MIRT468246 | SFXN4 | sideroflexin 4 | 2 | 2 | ||||||||
MIRT471589 | PAQR5 | progestin and adipoQ receptor family member 5 | 2 | 19 | ||||||||
MIRT476639 | G2E3 | G2/M-phase specific E3 ubiquitin protein ligase | 2 | 2 | ||||||||
MIRT482433 | ADM | adrenomedullin | 2 | 10 | ||||||||
MIRT486848 | PERP | PERP, TP53 apoptosis effector | 2 | 6 | ||||||||
MIRT489656 | SHMT1 | serine hydroxymethyltransferase 1 | 2 | 2 | ||||||||
MIRT493441 | KANSL1 | KAT8 regulatory NSL complex subunit 1 | 2 | 6 | ||||||||
MIRT493841 | FOXN3 | forkhead box N3 | 2 | 4 | ||||||||
MIRT501378 | RBFOX2 | RNA binding protein, fox-1 homolog 2 | 2 | 10 | ||||||||
MIRT509679 | ATAD5 | ATPase family, AAA domain containing 5 | 2 | 4 | ||||||||
MIRT510280 | MED28 | mediator complex subunit 28 | 2 | 2 | ||||||||
MIRT512221 | ATXN3 | ataxin 3 | 2 | 6 | ||||||||
MIRT514030 | BNIP2 | BCL2 interacting protein 2 | 2 | 2 | ||||||||
MIRT521375 | RDX | radixin | 2 | 4 | ||||||||
MIRT521444 | RAD51 | RAD51 recombinase | 2 | 2 | ||||||||
MIRT526055 | CBR1 | carbonyl reductase 1 | 2 | 2 | ||||||||
MIRT528658 | FUNDC2 | FUN14 domain containing 2 | 2 | 2 | ||||||||
MIRT529975 | TNFAIP8L1 | TNF alpha induced protein 8 like 1 | 2 | 2 | ||||||||
MIRT544098 | IPMK | inositol polyphosphate multikinase | 2 | 2 | ||||||||
MIRT545579 | SNRPA1 | small nuclear ribonucleoprotein polypeptide A' | 2 | 2 | ||||||||
MIRT547424 | MED4 | mediator complex subunit 4 | 2 | 2 | ||||||||
MIRT548955 | CD2AP | CD2 associated protein | 2 | 2 | ||||||||
MIRT549537 | NDUFA6 | NADH:ubiquinone oxidoreductase subunit A6 | 2 | 4 | ||||||||
MIRT552550 | ZFP36L2 | ZFP36 ring finger protein like 2 | 2 | 4 | ||||||||
MIRT554640 | ROBO1 | roundabout guidance receptor 1 | 2 | 2 | ||||||||
MIRT564904 | YTHDF1 | YTH N6-methyladenosine RNA binding protein 1 | 2 | 2 | ||||||||
MIRT565578 | SLC6A8 | solute carrier family 6 member 8 | 2 | 2 | ||||||||
MIRT568312 | BAG4 | BCL2 associated athanogene 4 | 2 | 2 | ||||||||
MIRT617891 | PTCHD3 | patched domain containing 3 | 2 | 2 | ||||||||
MIRT621892 | TAF13 | TATA-box binding protein associated factor 13 | 2 | 2 | ||||||||
MIRT642850 | RNF135 | ring finger protein 135 | 2 | 2 | ||||||||
MIRT665395 | WEE1 | WEE1 G2 checkpoint kinase | 2 | 2 | ||||||||
MIRT697879 | UBE2B | ubiquitin conjugating enzyme E2 B | 2 | 2 | ||||||||
MIRT698492 | THOC2 | THO complex 2 | 2 | 2 | ||||||||
MIRT701227 | OCRL | OCRL, inositol polyphosphate-5-phosphatase | 2 | 2 | ||||||||
MIRT701872 | MPLKIP | M-phase specific PLK1 interacting protein | 2 | 2 | ||||||||
MIRT707045 | TRPV2 | transient receptor potential cation channel subfamily V member 2 | 2 | 2 | ||||||||
MIRT715216 | NPVF | neuropeptide VF precursor | 2 | 2 |
miRNA-Drug Associations | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|